This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Johnson & Johnson Research Pty Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Gregory Martin Arndt: Innovator in Multitargeting Interfering RNAs
Introduction
Gregory Martin Arndt is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of genetic research, particularly in the design and application of interfering RNA molecules. His innovative work has the potential to advance gene regulation techniques.
Latest Patents
Arndt holds a patent for "Multitargeting interfering RNAs having two active strands and methods for their design and use." This patent describes a novel approach to designing and producing interfering RNA molecules that can specifically target multiple binding sequences in distinct genetic contexts. The multitargeting interfering RNA molecules consist of two strands that can modulate the expression of one or more pre-selected target RNA molecules. This innovative method provides a powerful tool for gene regulation.
Career Highlights
Gregory Arndt is associated with Johnson & Johnson Research Pty Limited, where he applies his expertise in genetic research. His work focuses on developing advanced RNA technologies that can enhance therapeutic strategies in various medical fields.
Collaborations
Arndt has collaborated with esteemed colleagues, including Laurent Pierre Rivory and Michael Poidinger. These partnerships have contributed to the advancement of research in the field of RNA technology.
Conclusion
Gregory Martin Arndt's contributions to the field of genetic research through his innovative patent on multitargeting interfering RNAs highlight his role as a leading inventor. His work continues to influence gene regulation strategies and holds promise for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
